Artwork
iconShare
 
Manage episode 517699549 series 3335332
Content provided by Clinical Research News. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clinical Research News or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

This episode of the Scope of Things features an exclusive panel at SCOPE Europe 2025 covering regulatory requirements for AI literacy training, featuring industry executives Jonathan Crowther, head of the operational design center at Merck KGaA; Janie Hansen, global development information management, business systems transformation at Daiichi Sankyo; Francis Kendall, head of statistical programming, digital and data sciences at Biogen; and James Weatherall, vice president and chief data scientist of biopharmaceuticals R&D at AstraZeneca. Plus, host Deborah Borfitz gives the latest news on efforts to reduce excess data collection in studies, whole genome sequencing of breast cancer, a virus cocktail to combat superbugs, and more.

Show Notes
News Roundup

Collaborative study on data collection in trials

  • News posted on the TransCelerate website

Heart benefits of semaglutide

Whole genome sequencing of breast cancers

  • Study in The Lancet Oncology

Pan-cancer immunotherapy heads to trials

Promising NAD+ “youth molecule”

Virus cocktail to combat superbugs

AI annotates medical images

  • News posted on the MIT website

Fitbits aid precision health

Latest from the Human Epilepsy Project

Imposter study participants

Guests

  • Jonathan Crowther, Ph.D., Head, Operational Design Center, Merck KGaA, Darmstadt, Germany
  • Janie Hansen, Global Development Information Management, Business Systems Transformation, Daiichi Sankyo
  • Francis Kendall, Head of Statistical Programming, Digital and Data Sciences, Biogen
  • James Weatherall, Ph.D., Vice President & Chief Data Scientist, BioPharmaceuticals R&D, AstraZeneca

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

  continue reading

Chapters

1. Episode 44 - SCOPE Europe 2025 on AI Literacy Training, Reducing Excess Data Collection, Combating Superbugs (00:00:00)

2. Welcome And Agenda (00:00:01)

3. Headlines Across Clinical Research (00:00:37)

4. Cutting Nonessential Trial Procedures (00:01:25)

5. Heart Benefits Of GLP-1 Drugs (00:02:23)

6. Whole Genome Sequencing In Breast Cancer (00:03:03)

7. Pan-Cancer Glycan Immunotherapies (00:04:04)

8. NAD Plus And Healthy Aging (00:04:48)

9. Phage Cocktail Against Superbugs (00:05:55)

10. Click-To-Segment Medical Imaging AI (00:06:32)

11. Wearables And Equitable Precision Health (00:07:29)

12. Epilepsy Treatment Resistance May Wane (00:08:26)

13. Imposter Participants Threaten Research Integrity (00:09:24)

14. Listener Engagement And Links (00:10:26)

15. Panel Intro: EU AI Act Literacy (00:10:44)

16. What Counts As AI Literacy Training (00:11:19)

17. Responsible AI Principles In Practice (00:12:42)

18. Data Literacy And Prompt Skills Gap (00:13:11)

19. Practical Training Resources And Academies (00:14:19)

20. Closing And Scope Summit Invitation (00:15:17)

45 episodes